-
1 Comment
American Renal Associates Holdings, Inc is currently in a long term uptrend where the price is trading 27.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
American Renal Associates Holdings, Inc's total revenue sank by 0.8% to $210M since the same quarter in the previous year.
Its net income has dropped by 156.3% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 34.7% to $15M since the same quarter in the previous year.
Based on the above factors, American Renal Associates Holdings, Inc gets an overall score of 2/5.
| Exchange | NYSE |
|---|---|
| CurrencyCode | USD |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| ISIN | US0292271055 |
| Market Cap | 398M |
|---|---|
| PE Ratio | None |
| Target Price | 10 |
| Dividend Yield | 11.% |
| Beta | 1.11 |
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ARA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
